Improvements to tiny body-on-a-chip devices could lead to next-generation pre-clinical testing of drug toxicity
Researchers at Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) in Japan have designed a small ‘body-on-a-chip’ device that can test the side effects of drugs s on human cells. The device solves some issues with current, similar microfluidic devices and offers promise for the next generation of pre-clinical drug tests.
The Integrated Heart/Cancer on a Chip (iHCC) was used to test the toxicity of the anti-cancer drug doxorubicin on heart cells. The researchers, led by iCeMS’s Ken-ichiro Kamei, found that, while the drug itself was not toxic to heart cells, a metabolite of the drug resulting from its interaction with cancer cells was.
The device is smaller than a microscope glass slide. It contains six tiny chambers; every two are connected by microchannels with a series of port inlets and valves. A pneumatic pump controls movement of fluid through the channels. Every two chambers and their separate microchannel system constitute one test bed. Three test beds in the device allow for the introduction of minor changes in each bed to simultaneously compare results.
The team first tested doxorubicin’s effects on heart cells and liver cancer cells cultured separately in small wells. The drug had the expected anti-cancer effect on the cancer cells without causing damage to the heart cells.
They then ran the test using the iHCC device. Heart cells were placed in one chamber while liver cancer cells were placed in the other. Doxorubicin was introduced into a cell culture medium circulating through a closed-loop system of microchannels that connects the two chambers, mimicking the blood’s circulatory system. In this way, the drug flows unidirectionally in a continuous loop through both chambers.
The team found signs of toxicity in both cancer and heart cells. They hypothesized that a compound, doxorubicinol, which is a metabolic byproduct of doxorubicin interacting with cancer cells, was causing the toxic effect.
To test this, they added doxorubicinol to heart cells and liver cancer cells cultured separately in small wells. It was toxic to the heart cells but not to the cancer cells.
When doxorubicin alone is added to the liver cancer cells, the amount of doxorubicinol produced is too small to be toxic to the heart cells. The team believes this is because the amount of cell culture medium needed for the well-based tests dilutes the metabolite.
In contrast, when doxorubicin is introduced into the iHCC, the metabolite is not diluted when moving through the microchannel circulation system because a smaller volume of cell culture is needed. As a result, the drug does have a toxic effect on the heart cells via its metabolite.
The device requires further improvements, but the study demonstrates how this design concept could be used to investigate the toxic side effects of anti-cancer drugs on heart cells well before expensive clinical trials. The study was published in the journal Royal Society of Chemistry Advances.
Learn more: Next-generation drug testing on chips
The Latest on: Body-on-a-chip
[google_news title=”” keyword=”body-on-a-chip” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Chip Zien (‘Harmony’) explores guilt and history in ‘the role of a lifetime’ [Exclusive Video Interview]on April 16, 2024 at 9:30 am
It’s the role of a lifetime,” exclaims Chip Zien in reference to his character Rabbi in “Harmony.” The actor’s agents were initially hesitant to send him the script for the Barry Manilow and Bruce ...
- Commercial featuring nuns taking potato chips for communion sparks outrage in Italyon April 16, 2024 at 5:34 am
A potato chip commercial that features nuns receiving the crispy snacks for communion is “blasphemy” and should be taken off the air, according to an Italian Catholic organization.
- Regulators pull potato chip ad that stoked outrage for mocking Eucharist: 'This is a hate crime'on April 12, 2024 at 2:38 pm
Italy s advertising standards authority pulled a 30-second TV ad by an Italian snack company after it stoked outrage and accusations of blasphemy among Roman Catholics for replacing the Eucharist ...
- South African Electoral Body Appeals Ruling on Zuma Candidacyon April 12, 2024 at 12:48 am
South Africa’s electoral commission asked the Constitutional Court to provide clarity on a ruling this week that allows former President Jacob Zuma to run for parliament in next month’s elections.Most ...
- The one filling snack Michael Pollan swears by to curb his insatiable craving for potato chipson April 11, 2024 at 12:24 pm
Michael Pollan, a food writer, shares his secret to eating less processed snacks.
- Commercial featuring nuns taking potato chips for communion sparks outrage in Italyon April 9, 2024 at 5:00 pm
A potato chip commercial that features nuns receiving ... Catholics believe the communion wafer represents the body and blood of Christ. Giovanni Baggio, the head of AIART, a Catholic group ...
- The Body & Dis Fig Reveal North American Tour Dates for Summer 2024on April 9, 2024 at 3:21 pm
Following the release of their acclaimed debut collaborative album Orchards of a Futile Heaven, The Body & Dis Fig have announced a collaborative tour throughout North America this Summer. The shows ...
- Rev. Cecil ‘Chip’ Murray, voice of calm during L.A. riots, dies at 94on April 8, 2024 at 8:43 am
Rev. Murray presided over the city’s oldest Black congregation, the First African Methodist Episcopal Church in South Los Angeles, turning a struggling community into an 18,000-member powerhouse that ...
- Brown researchers develop chip network technology to transmit, receive complex dataon April 7, 2024 at 7:04 pm
Brown researchers developed an “asynchronous wireless network” for microelectronic chips to transmit and receive data from biomedical devices using a system that mimics how neurons in the brain ...
via Google News and Bing News